Home / Market News / $ARGX
fiscal.ai Corporate Catalyst Impact 65/100 ● positive

DZ Bank Raises Price Target for argenx

Oct 23, 2026, 3:32 PM UTC · Primary ticker $ARGX

DZ Bank raised its price target for argenx to 935 EUR from 861 EUR, maintaining a 'Buy' rating. This upgrade is attributed to VYVGART product sales surpassing market expectations, following the company's recent quarterly results, indicating positive sentiment for the stock.

DZ Bank analyst Elmar Kraus increased the fair value for argenx from 861 EUR to 935 EUR, while reiterating a 'Buy' rating. This positive adjustment stems from the strong performance of argenx's flagship therapy, VYVGART, which reported product sales exceeding market expectations in its recent quarterly results. This news is a positive catalyst for argenx, as it signals analyst confidence in the company's commercial execution and future revenue potential. In the short term, this could lead to increased investor interest and upward pressure on the stock price. Long-term implications suggest continued growth for VYVGART and potentially other pipeline assets. A key opportunity for traders is to capitalize on the positive momentum driven by strong product performance and analyst upgrades.

$ARGX positive Price target increase due to strong product sales
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.